Stay updated on Eli Lilly and Company Press Releases

Sign up to get notified when there's something new on the Eli Lilly and Company Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Eli Lilly and Company Press Releases page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    Important update:The change on the webpage from announcing the extension of the tender offer to acquire POINT Biopharma to Lilly's participation in Cowen's 44th Annual Health Care Conference represents a shift in focus from a corporate acquisition strategy to engaging in a financial conference to discuss industry developments and financial outlook. This change indicates a strategic pivot in Eli Lilly and Company's current priorities and activities within the healthcare sector.
    Difference
    12%
    Check dated 2024-02-20T20:45:03.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    Important update:The change on the webpage represents the announcement that Philip Johnson, group vice president and treasurer of Eli Lilly and Company, will retire from the company at the end of February 2024 to pursue a new professional opportunity.
    Difference
    12%
    Check dated 2024-02-10T10:54:08.000Z thumbnail image
  8. Check
    24 days ago
    Change Detected
    Summary
    Important update:The change on the webpage represents the financial results and guidance provided by Lilly in their strong fourth-quarter 2023 report. The revenue in Q4 2023 increased by 28%, with significant growth in revenue from new products like Mounjaro and Zepbound, as well as growth products like Verzenio and Jardiance.
    Difference
    14%
    Check dated 2024-02-07T07:55:31.000Z thumbnail image
  9. Check
    39 days ago
    Change Detected
    Summary
    Important update:The change on the webpage represents the announcement of positive Phase 1/2 clinical trial data for an investigational gene therapy for genetic hearing loss, which will be presented at the Association for Research in Otolaryngology 2024 MidWinter Meeting.
    Difference
    28%
    Check dated 2024-01-23T18:59:13.000Z thumbnail image

Stay in the know with updates to Eli Lilly and Company Press Releases

Enter your email address, and we'll notify you when there's something new on the Eli Lilly and Company Press Releases page.